In addition to validating the high expression of CD200 in endothelial cells in bioletters, flow cytometry also found that epithelial cells and CD4+ T cells also expressed CD200 in three tumors, and fibroblasts in colorectal cancer were highly expressed CD200 (Figures 8I, 9I, 10I). Here, CD4 is linked to colorectal cancer.